These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33138909)

  • 1. Treatment of Children Hemangiomas.
    Ţarcă E
    Chirurgia (Bucur); 2020; 115(5):643-649. PubMed ID: 33138909
    [No Abstract]   [Full Text] [Related]  

  • 2. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
    Kardasevic M; Dinarevic SM
    Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical timolol for small hemangiomas of infancy.
    Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
    Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile Hemangiomas in the Head and Neck Region.
    Adams DM; Ricci KW
    Otolaryngol Clin North Am; 2018 Feb; 51(1):77-87. PubMed ID: 29217069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episcleral infantile hemangioma successfully treated with topical timolol.
    Ciudad Blanco C; Campos Domínguez M; Moreno García B; Villanueva Álvarez-Santullano CA; Berenguer Fröhner B; Suárez Fernández R
    Dermatol Ther; 2015; 28(1):22-4. PubMed ID: 25286087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?
    Javia LR; Zur KB; Jacobs IN
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1450-4. PubMed ID: 21880377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
    Chang TC; Estes R
    J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
    Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
    López-Gutiérrez JC
    Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subglottic hemangioma: Understanding the association with facial segmental hemangioma in a beard distribution.
    McCormick AA; Tarchichi T; Azbell C; Grunwaldt L; Jabbour N
    Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():34-37. PubMed ID: 30174006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol treatment for hemangioma of infancy.
    Bonini FK; Bellodi FS; Souza EM
    An Bras Dermatol; 2011; 86(4):763-6. PubMed ID: 21987146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas.
    Schneider M; Reimer A; Cremer H; Ruef P
    World J Pediatr; 2014 Nov; 10(4):313-7. PubMed ID: 25515804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
    MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
    J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
    Düzenli Kar Y; Özdemir ZC; Acu B; Bör Ö
    Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.